AJP - Regu Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 295: R59-R66, 2008. First published April 30, 2008; doi:10.1152/ajpregu.00833.2007
0363-6119/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Information
Right arrow All Versions of this Article:
295/1/R59    most recent
00833.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Looft-Wilson, R. C.
Right arrow Articles by Bearden, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Looft-Wilson, R. C.
Right arrow Articles by Bearden, S. E.

APPETITE, OBESITY, AND DIGESTION

Chronic diet-induced hyperhomocysteinemia impairs eNOS regulation in mouse mesenteric arteries

Robin C. Looft-Wilson,1 Blair S. Ashley,1 Janelle E. Billig,1 Madeline R. Wolfert,1 Lindsay A. Ambrecht,1 and Shawn E. Bearden2

1College of William and Mary, Department of Kinesiology, Williamsburg, Virginia; and 2Idaho State University, Biological Sciences, Pocatello, Idaho

Submitted 7 November 2007 ; accepted in final form 30 April 2008

Hyperhomocysteinemia (HHcy) impairs endothelium-dependent vasodilation by increasing reactive oxygen species, thereby reducing nitric oxide (NO·) bioavailability. It is unclear whether reduced expression or function of the enzyme that produces NO·, endothelial nitric oxide synthase (eNOS), also contributes. It is also unclear whether resistance vessels that utilize both NO·and non-NO·vasodilatory mechanisms, undergo alteration of non-NO·mechanisms in this condition. We tested these hypotheses in male C57BL/6 mice with chronic HHcy induced by 6-wk high methionine/low-B vitamin feeding (Hcy: 89.2 ± 49.0 µM) compared with age-matched controls (Hcy: 6.6 ± 1.9 µM), using first-order mesenteric arteries. Dilation to ACh (10–9–10–4 M) was measured in isolated, cannulated, and pressurized (75 mmHg) arteries with and without NG-nitro-L-arginine methyl ester (L-NAME) (10–4 M) and/or indomethacin (10–5 M) to test endothelium-dependent dilation and non-NO·-dependent dilation, respectively. The time course of dilation to ACh (10–4 M) was examined to compare the initial transient dilation due to non-NO·, non-prostacyclin mechanism and the sustained dilation due to NO·. These experiments indicated that endothelium-dependent dilation was attenuated (P < 0.05) in HHcy arteries due to downregulation of only NO·-dependent dilation. Western blot analysis indicated significantly less (P < 0.05) basal eNOS and phospho-S1179-eNOS/eNOS in mesenteric arteries from HHcy mice but no difference in phospho-T495-eNOS/eNOS. S1179 eNOS phosphorylation was also significantly less in these arteries when stimulated with ACh ex vivo or in situ. Real-time PCR indicated no difference in eNOS mRNA levels. In conclusion, chronic diet-induced HHcy in mice impairs eNOS protein expression and phosphorylation at S1179, coincident with impaired NO·-dependent dilation, which implicates dysfunction in eNOS post-transcriptional regulation in the impaired endothelium-dependent vasodilation and microvascular disease that is common with HHcy.

homocysteine; endothelial nitric oxide synthase; S1179; vasodilation



Address for reprint requests and other correspondence: R. Looft-Wilson, Dept. of Kinesiology, College of William and Mary, P.O. Box 8795, Williamsburg, VA 23187-8795 (e-mail: rlooft{at}wm.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.